Risk of CV Events With EFV vs. EFV-free Regimens
NCT02426866 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29612
Last updated 2015-04-27
Summary
The purpose of this study is to determine whether there is an increased risk of cardiovascular events (CV) with regimens containing efavirenz (EFV) versus other regimens in patients with HIV.
Conditions
Interventions
- DRUG
-
Efavirenz
Sponsors & Collaborators
-
Truven health
collaborator UNKNOWN - lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2015-01-31
- Completion
- 2015-01-31
More Related Trials
-
A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients
NCT00002448 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults.
NCT01011413 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
NCT00002195 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy
NCT00344760 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
NCT00050895 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
NCT00002398 ·Status: COMPLETED ·Phase: NA
-
Efavirenz (EFV) Intensification
NCT07193875 ·Status: COMPLETED ·Phase: PHASE4
-
A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)
NCT01632345 ·Status: COMPLETED ·Phase: PHASE2
-
A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy
NCT00053638 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
NCT02607930 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Neurologic and Psychiatric Adverse Events of Several Antiretroviral Drugs in Real Life Setting
NCT02882230 ·Status: TERMINATED
-
The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
NCT00001087 ·Status: COMPLETED ·Phase: PHASE2
-
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects
NCT00549198 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors
NCT01474954 ·Status: TERMINATED
-
A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1
NCT00824421 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients
NCT00823966 ·Status: COMPLETED
-
Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
NCT00005000 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
NCT02397694 ·Status: COMPLETED ·Phase: PHASE2
-
Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
NCT00112047 ·Status: COMPLETED ·Phase: PHASE3
-
Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects
NCT00960622 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002369 ·Status: COMPLETED ·Phase: NA
-
Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
NCT00802802 ·Status: COMPLETED ·Phase: PHASE1
-
Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage
NCT00556634 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
NCT00892437 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children
NCT00364793 ·Status: COMPLETED ·Phase: PHASE1/PHASE2